Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2007Hematology

TTP and ADAMTS13: When Is Testing Appropriate?

View Full Paper
Ask AI
Bookmark
Share

Authors

Pier Mannuccio Mannucci
Pier Mannuccio MannucciUniversità Cattolica del Sacro CuoreFPFlora PeyvandiBroad Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mannucci et al. (2007) studied this question.

synapsesocial.com/papers/6aa503e16803e1e7a1f2e50chttps://doi.org/10.1182/asheducation-2007.1.121
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1von Willebrand factor cleaving protease (ADAMTS‐13) and ADAMTS‐13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura2004 · 159 citations
  2. 2ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission2008 · 279 citations
  3. 3The course of ADAMTS‐13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine2005 · 86 citations
  4. 4Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura2004 · 453 citations
  5. 5Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange2005 · 66 citations